Welcome to LookChem.com Sign In|Join Free
  • or
Duocarmycin SA is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

130288-24-3

Post Buying Request

130288-24-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130288-24-3 Usage

Uses

Duocarmycin SA is an antitumor antibiotic.

Check Digit Verification of cas no

The CAS Registry Mumber 130288-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,2,8 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 130288-24:
(8*1)+(7*3)+(6*0)+(5*2)+(4*8)+(3*8)+(2*2)+(1*4)=103
103 % 10 = 3
So 130288-24-3 is a valid CAS Registry Number.
InChI:InChI=1/C25H23N3O7/c1-32-17-6-11-5-14(26-19(11)22(34-3)21(17)33-2)23(30)28-10-12-9-25(12)13-7-15(24(31)35-4)27-20(13)16(29)8-18(25)28/h5-8,12,26-27H,9-10H2,1-4H3/t12-,25-/m1/s1

130288-24-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (+)-duocarmycin SA

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130288-24-3 SDS

130288-24-3Synthetic route

methyl (S)-4-hydroxy-8-(hydroxymethyl)-6-(5,6,7-trimethoxy-1Hindole-2-carbonyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carboxylate

methyl (S)-4-hydroxy-8-(hydroxymethyl)-6-(5,6,7-trimethoxy-1Hindole-2-carbonyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carboxylate

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With tributylphosphine; azodicarbonyl dimorpholide In tetrahydrofuran for 2h; Inert atmosphere; enantioselective reaction;94%
With tributylphosphine; 1,1'-azodicarbonyl-dipiperidine In tetrahydrofuran for 0.333333h; Inert atmosphere;
(8S)-4-hydroxy-8-methanesulfonyloxymethyl-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,6,7,8-tetrahydro-3,6-diaza-as-indacene-2-carboxylic acid methyl ester

(8S)-4-hydroxy-8-methanesulfonyloxymethyl-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,6,7,8-tetrahydro-3,6-diaza-as-indacene-2-carboxylic acid methyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 23℃; for 1h;92%
duocarmycin
144667-38-9

duocarmycin

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile for 3h; Ambient temperature;91%
With sodium hydride In tetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 0.5h;87%
With sodium hydride In tetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 30h;
With sodium hydrogencarbonate In N,N-dimethyl-formamide at 25℃; for 1h;
methyl (S)-4-[(5,6,7-trimethoxyindol-2yl)carbonyl]-2,6-dihydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate
919535-11-8

methyl (S)-4-[(5,6,7-trimethoxyindol-2yl)carbonyl]-2,6-dihydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With tributylphosphine; 1,1'-azodicarbonyl-dipiperidine In tetrahydrofuran at 25℃; for 0.5h; Mitsunobu reaction;62%
(R)-8-Chloromethyl-4-hydroxy-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,6,7,8-tetrahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

(R)-8-Chloromethyl-4-hydroxy-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,6,7,8-tetrahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 30h;
C13H12N2O3

C13H12N2O3

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole
157425-68-8

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With sodium hydride 1.) DMF, THF, 2.) DMF, THF, 0 deg C; Yield given. Multistep reaction;
(+)-(7bR,8aS)-methyl 4-oxo-1,2,4,5,8,8a-hexahydrocyclopropapyrrolo<3,2-e>indole-6-carboxylate
150992-82-8

(+)-(7bR,8aS)-methyl 4-oxo-1,2,4,5,8,8a-hexahydrocyclopropapyrrolo<3,2-e>indole-6-carboxylate

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole
157425-68-8

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With sodium hydride 1.) DMF-THF, 2.) 0 deg C; Yield given. Multistep reaction;
With sodium hydride 1.) THF, DMF, 0 deg C, 20 min, 2.) THF, DMF, 0 deg C, 4 h; Yield given. Multistep reaction;
methyl (7bS)-(-)-1,2,4,5,8,8a-hexahydro-4-oxocyclopropapyrrolo<3,2-e>indole-6-carboxylate
151062-83-8

methyl (7bS)-(-)-1,2,4,5,8,8a-hexahydro-4-oxocyclopropapyrrolo<3,2-e>indole-6-carboxylate

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole
157425-68-8

1-(5,6,7-trimethoxyindole-2-carbonyl)imidazole

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
With sodium hydride 1.) THF, DMF, 0 deg C, 20 min, 2.) THF, DMF, 0 deg C, 4 h; Yield given. Multistep reaction;
3-(benzyloxy)-5-nitrobenzaldehyde
881422-32-8

3-(benzyloxy)-5-nitrobenzaldehyde

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: 78 percent / NaOMe / methanol; tetrahydrofuran / 17 h / -25 °C
2.1: 68 percent / xylene / 7 h / 140 °C
3.1: 98 percent / DMAP / tetrahydrofuran / 1 h / 25 °C
4.1: 98 percent / Zn; NH4Cl / acetone; H2O / 0.5 h / 25 °C
5.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
6.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
7.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
8.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
8.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
9.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
10.1: HCl / ethyl acetate / 3 h / 25 °C
11.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
12.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl 2-azido-3-(3-benzyloxy-5-nitrophenyl)acrylate

methyl 2-azido-3-(3-benzyloxy-5-nitrophenyl)acrylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 68 percent / xylene / 7 h / 140 °C
2.1: 98 percent / DMAP / tetrahydrofuran / 1 h / 25 °C
3.1: 98 percent / Zn; NH4Cl / acetone; H2O / 0.5 h / 25 °C
4.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
5.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
6.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
7.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
7.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
8.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
9.1: HCl / ethyl acetate / 3 h / 25 °C
10.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
11.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
4,8-dihydroxy-6,7,8,9-tetrahydro-3H-pyrrolo[3,2-f]quinoline-2-carboxylic acid methyl ester

4,8-dihydroxy-6,7,8,9-tetrahydro-3H-pyrrolo[3,2-f]quinoline-2-carboxylic acid methyl ester

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
2: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl (S)-4,7-di-tert-butoxycarbonyl-2,6-dihydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate
919535-09-4

methyl (S)-4,7-di-tert-butoxycarbonyl-2,6-dihydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: HCl / ethyl acetate / 3 h / 25 °C
2: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
3: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
1-(1,1-dimethylethyl)-2-methyl 5-[[(1,1-dimethylethoxy)-carbonyl]amino]-4-iodo-7-(phenylmethoxy)indole-1,2-dicarboxylate
919535-06-1

1-(1,1-dimethylethyl)-2-methyl 5-[[(1,1-dimethylethoxy)-carbonyl]amino]-4-iodo-7-(phenylmethoxy)indole-1,2-dicarboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
2.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
2.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
3.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
4.1: HCl / ethyl acetate / 3 h / 25 °C
5.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
6.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl (S)-4,7-di-tert-butoxycarbonyl-6-benzyloxy-2-hydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate
919535-08-3

methyl (S)-4,7-di-tert-butoxycarbonyl-6-benzyloxy-2-hydroxy-1,2,3,4-tetrahydropyrrolo[3,2-f]quinoline-8-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
2: HCl / ethyl acetate / 3 h / 25 °C
3: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
4: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl (R)-7-benzyloxy-1-(tert-butoxycarbonyl)-5-(tert-butoxycarbonyl-(oxiran-2-ylmethyl)amino)-4-iodoindole-2-carboxylate
919535-07-2

methyl (R)-7-benzyloxy-1-(tert-butoxycarbonyl)-5-(tert-butoxycarbonyl-(oxiran-2-ylmethyl)amino)-4-iodoindole-2-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
1.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
2.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
3.1: HCl / ethyl acetate / 3 h / 25 °C
4.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
5.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
3,5-dinitrobenzaldehyde
14193-18-1

3,5-dinitrobenzaldehyde

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: syn-benzaldehyde oxime; K2CO3 / dimethylformamide / 1.25 h / 90 °C
1.2: 86 percent / dimethylformamide / 2 h / 25 °C
2.1: 78 percent / NaOMe / methanol; tetrahydrofuran / 17 h / -25 °C
3.1: 68 percent / xylene / 7 h / 140 °C
4.1: 98 percent / DMAP / tetrahydrofuran / 1 h / 25 °C
5.1: 98 percent / Zn; NH4Cl / acetone; H2O / 0.5 h / 25 °C
6.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
7.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
8.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
9.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
9.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
10.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
11.1: HCl / ethyl acetate / 3 h / 25 °C
12.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
13.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl 7-(benzyloxy)-5-nitro-1H-indole-2-carboxylate
539856-42-3

methyl 7-(benzyloxy)-5-nitro-1H-indole-2-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: 98 percent / DMAP / tetrahydrofuran / 1 h / 25 °C
2.1: 98 percent / Zn; NH4Cl / acetone; H2O / 0.5 h / 25 °C
3.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
4.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
5.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
6.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
6.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
7.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
8.1: HCl / ethyl acetate / 3 h / 25 °C
9.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
10.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
1-(1,1-dimethylethyl)-2-methyl-5-nitro-6-(phenylmethoxy)-indole-1,2-dicarboxylate
539856-49-0

1-(1,1-dimethylethyl)-2-methyl-5-nitro-6-(phenylmethoxy)-indole-1,2-dicarboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: 98 percent / Zn; NH4Cl / acetone; H2O / 0.5 h / 25 °C
2.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
3.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
4.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
5.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
5.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
6.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
7.1: HCl / ethyl acetate / 3 h / 25 °C
8.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
9.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl 5-amino-7-(benzyloxy)-1-(tert-butoxycarbonyl)indole-2-carboxylate
539856-43-4

methyl 5-amino-7-(benzyloxy)-1-(tert-butoxycarbonyl)indole-2-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: 227 mg / tetrahydrofuran / 10 h / 25 °C
2.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
3.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
4.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
4.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
5.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
6.1: HCl / ethyl acetate / 3 h / 25 °C
7.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
8.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
methyl 7-(benzyloxy)-1-(tert-butoxycarbonyl)-5-[(tert-butoxycarbonyl)amino]indole-2-carboxylate
539856-50-3

methyl 7-(benzyloxy)-1-(tert-butoxycarbonyl)-5-[(tert-butoxycarbonyl)amino]indole-2-carboxylate

A

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

B

calf thymus DNA

calf thymus DNA

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: 91 percent / N-iodosuccinimide; AcOH / toluene / 8 h / 25 °C
2.1: 96 percent / NaH / dimethylformamide / 2 h / 0 °C
3.1: i-PrMgBr / tetrahydrofuran / 1 h / -40 °C
3.2: 69 percent / CuI; Bu3P / tetrahydrofuran / 1.5 h / -78 - -40 °C
4.1: 82 percent / H2 / Pd/C / methanol; tetrahydrofuran / 0.5 h / 25 °C
5.1: HCl / ethyl acetate / 3 h / 25 °C
6.1: 3.7 mg / EDCI / dimethylformamide / 2 h / 0 °C
7.1: 62 percent / Bu3P; ADDP / tetrahydrofuran / 0.5 h / 25 °C
View Scheme
p-nitrophenyl methanesulfonate
20455-07-6

p-nitrophenyl methanesulfonate

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 26 steps
1.1: 100 percent / H2 / Ra-Ni / ethyl acetate; ethanol / 24 h / 23 °C / 72400.7 Torr
2.1: 94.5 g / Br2 / methanol; CH2Cl2 / 0.5 h / 0 - 23 °C
3.1: aq. NaNO2; H2SO4 / acetonitrile / 0 °C
3.2: 96 percent / aq. KI / acetonitrile / 0.75 h
4.1: 100 percent / KOH / CH2Cl2; methanol / 0.08 h / 23 °C
5.1: 88 percent / K2CO3 / dimethylformamide / 1 h / 23 °C
6.1: n-BuLi / toluene; hexane / -78 °C
6.2: 4.18 g / toluene
7.1: aq. acetic acid / 3 h / 100 °C
8.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
9.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
10.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
11.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
12.1: K2CO3 / dimethylformamide / 1 h / 23 °C
13.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
14.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
15.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
16.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
16.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
17.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
18.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
19.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
20.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
21.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
22.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
23.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
24.1: 88 percent / pyridine / 0.17 h / 23 °C
25.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
26.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
methanesulfonic acid 4-aminophenyl ester
24690-19-5

methanesulfonic acid 4-aminophenyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 25 steps
1.1: 94.5 g / Br2 / methanol; CH2Cl2 / 0.5 h / 0 - 23 °C
2.1: aq. NaNO2; H2SO4 / acetonitrile / 0 °C
2.2: 96 percent / aq. KI / acetonitrile / 0.75 h
3.1: 100 percent / KOH / CH2Cl2; methanol / 0.08 h / 23 °C
4.1: 88 percent / K2CO3 / dimethylformamide / 1 h / 23 °C
5.1: n-BuLi / toluene; hexane / -78 °C
5.2: 4.18 g / toluene
6.1: aq. acetic acid / 3 h / 100 °C
7.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
8.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
9.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
10.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
11.1: K2CO3 / dimethylformamide / 1 h / 23 °C
12.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
13.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
14.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
15.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
15.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
16.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
17.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
18.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
19.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
20.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
21.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
22.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
23.1: 88 percent / pyridine / 0.17 h / 23 °C
24.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
25.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
2-bromo-3,4,5-tri-methoxybenzaldehyde
35274-53-4

2-bromo-3,4,5-tri-methoxybenzaldehyde

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 97 percent / 1,1,3,3-tetramethylguanidine / CH2Cl2 / 48 h / 23 °C
2: 98 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
3: 99 percent / H2 / Pd/C / ethyl acetate; ethanol / 3 h / 23 °C
4: 89 percent / aq. KOH / methanol / 1 h / Heating
5: SOCl2; DMF / toluene / 0.33 h / 70 °C
6: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
7: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
8: 88 percent / pyridine / 0.17 h / 23 °C
9: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
10: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
Multi-step reaction with 9 steps
1.1: potassium acetate / tetrahydrofuran / 2 h / 60 °C / Inert atmosphere
2.1: triethylamine / methanol / 0.5 h / 60 °C
3.1: 1,10-Phenanthroline; potassium carbonate; copper(l) iodide / N,N-dimethyl-formamide / 2 h / 80 °C / Inert atmosphere
4.1: water; tetrahydrofuran / 3 h / 60 °C / Inert atmosphere
5.1: oxalyl dichloride / N,N-dimethyl-formamide; tetrahydrofuran / 1 h / Inert atmosphere
5.2: Reflux
6.1: 2,6-dimethylpyridine / dichloromethane / 0.5 h / 2.2 °C / Inert atmosphere
7.1: 10 wt% Pd(OH)2 on carbon; hydrogen; ammonium formate / methanol / 1 h / 35 - 50 °C / Inert atmosphere
8.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1 h / 35 °C / Inert atmosphere
9.1: tributylphosphine; azodicarbonyl dimorpholide / tetrahydrofuran / 2 h / Inert atmosphere
View Scheme
5,6,7-trimethoxy-1H-indole-2-carboxylic acid
128781-07-7

5,6,7-trimethoxy-1H-indole-2-carboxylic acid

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: SOCl2; DMF / toluene / 0.33 h / 70 °C
2: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
3: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
4: 88 percent / pyridine / 0.17 h / 23 °C
5: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
6: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
Multi-step reaction with 2 steps
1: EDCI, NaHCO3 / dimethylformamide / 15 h / 25 °C
2: 87 percent / NaH / tetrahydrofuran; dimethylformamide / 0.5 h / 0 °C
View Scheme
Multi-step reaction with 5 steps
1.1: oxalyl dichloride / N,N-dimethyl-formamide; tetrahydrofuran / 1 h / Inert atmosphere
1.2: Reflux
2.1: 2,6-dimethylpyridine / dichloromethane / 0.5 h / 2.2 °C / Inert atmosphere
3.1: 10 wt% Pd(OH)2 on carbon; hydrogen; ammonium formate / methanol / 1 h / 35 - 50 °C / Inert atmosphere
4.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1 h / 35 °C / Inert atmosphere
5.1: tributylphosphine; azodicarbonyl dimorpholide / tetrahydrofuran / 2 h / Inert atmosphere
View Scheme
Multi-step reaction with 6 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / tetrahydrofuran / 0.5 h
2.1: 2,6-dimethylpyridine / dichloromethane / 0.5 h
3.1: zinc; acetic acid / acetonitrile / 72 h
4.1: magnesium sulfate / dichloromethane / 23 h
4.2: 4 h / 50 °C
5.1: 20% palladium hydroxide-activated charcoal; ammonium formate; methanol / water / 50 °C / Inert atmosphere
5.2: 3 h / 35 °C / Inert atmosphere
6.1: tributylphosphine; 1,1'-azodicarbonyl-dipiperidine / tetrahydrofuran / 0.33 h / Inert atmosphere
View Scheme
5,6,7-trimethoxy-1H-indole-2-carboxylic acid methyl ester
118292-37-8

5,6,7-trimethoxy-1H-indole-2-carboxylic acid methyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 89 percent / aq. KOH / methanol / 1 h / Heating
2: SOCl2; DMF / toluene / 0.33 h / 70 °C
3: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
4: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
5: 88 percent / pyridine / 0.17 h / 23 °C
6: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
7: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
3,4,5-trimethoxy-benzaldehyde
86-81-7

3,4,5-trimethoxy-benzaldehyde

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1: 87 percent / Br2; AcOH / CH2Cl2 / 0.5 h / 0 °C
2: 97 percent / 1,1,3,3-tetramethylguanidine / CH2Cl2 / 48 h / 23 °C
3: 98 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
4: 99 percent / H2 / Pd/C / ethyl acetate; ethanol / 3 h / 23 °C
5: 89 percent / aq. KOH / methanol / 1 h / Heating
6: SOCl2; DMF / toluene / 0.33 h / 70 °C
7: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
8: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
9: 88 percent / pyridine / 0.17 h / 23 °C
10: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
11: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
Multi-step reaction with 10 steps
1.1: N-Bromosuccinimide / acetonitrile / 1 h / 50 °C / Inert atmosphere
2.1: potassium acetate / tetrahydrofuran / 2 h / 60 °C / Inert atmosphere
3.1: triethylamine / methanol / 0.5 h / 60 °C
4.1: 1,10-Phenanthroline; potassium carbonate; copper(l) iodide / N,N-dimethyl-formamide / 2 h / 80 °C / Inert atmosphere
5.1: water; tetrahydrofuran / 3 h / 60 °C / Inert atmosphere
6.1: oxalyl dichloride / N,N-dimethyl-formamide; tetrahydrofuran / 1 h / Inert atmosphere
6.2: Reflux
7.1: 2,6-dimethylpyridine / dichloromethane / 0.5 h / 2.2 °C / Inert atmosphere
8.1: 10 wt% Pd(OH)2 on carbon; hydrogen; ammonium formate / methanol / 1 h / 35 - 50 °C / Inert atmosphere
9.1: tetrabutyl ammonium fluoride / tetrahydrofuran / 1 h / 35 °C / Inert atmosphere
10.1: tributylphosphine; azodicarbonyl dimorpholide / tetrahydrofuran / 2 h / Inert atmosphere
View Scheme
3,5-dibromo-4-iodophenyjl
556038-75-6

3,5-dibromo-4-iodophenyjl

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 22 steps
1.1: 88 percent / K2CO3 / dimethylformamide / 1 h / 23 °C
2.1: n-BuLi / toluene; hexane / -78 °C
2.2: 4.18 g / toluene
3.1: aq. acetic acid / 3 h / 100 °C
4.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
5.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
6.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
7.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
8.1: K2CO3 / dimethylformamide / 1 h / 23 °C
9.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
10.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
11.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
12.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
12.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
13.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
14.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
15.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
16.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
17.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
18.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
19.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
20.1: 88 percent / pyridine / 0.17 h / 23 °C
21.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
22.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
methanesulfonic acid 4-amino-3,5-dibromophenyl ester
556038-73-4

methanesulfonic acid 4-amino-3,5-dibromophenyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 24 steps
1.1: aq. NaNO2; H2SO4 / acetonitrile / 0 °C
1.2: 96 percent / aq. KI / acetonitrile / 0.75 h
2.1: 100 percent / KOH / CH2Cl2; methanol / 0.08 h / 23 °C
3.1: 88 percent / K2CO3 / dimethylformamide / 1 h / 23 °C
4.1: n-BuLi / toluene; hexane / -78 °C
4.2: 4.18 g / toluene
5.1: aq. acetic acid / 3 h / 100 °C
6.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
7.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
8.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
9.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
10.1: K2CO3 / dimethylformamide / 1 h / 23 °C
11.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
12.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
13.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
14.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
14.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
15.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
16.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
17.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
18.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
19.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
20.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
21.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
22.1: 88 percent / pyridine / 0.17 h / 23 °C
23.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
24.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
methanesulfonic acid 3,5-dibromo-4-iodophenyl ester
556038-74-5

methanesulfonic acid 3,5-dibromo-4-iodophenyl ester

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 23 steps
1.1: 100 percent / KOH / CH2Cl2; methanol / 0.08 h / 23 °C
2.1: 88 percent / K2CO3 / dimethylformamide / 1 h / 23 °C
3.1: n-BuLi / toluene; hexane / -78 °C
3.2: 4.18 g / toluene
4.1: aq. acetic acid / 3 h / 100 °C
5.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
6.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
7.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
8.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
9.1: K2CO3 / dimethylformamide / 1 h / 23 °C
10.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
11.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
12.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
13.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
13.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
14.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
15.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
16.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
17.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
18.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
19.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
20.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
21.1: 88 percent / pyridine / 0.17 h / 23 °C
22.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
23.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
3,5-dibromo-4-iodophenol benzyl ether
556038-43-8

3,5-dibromo-4-iodophenol benzyl ether

(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

Conditions
ConditionsYield
Multi-step reaction with 21 steps
1.1: n-BuLi / toluene; hexane / -78 °C
1.2: 4.18 g / toluene
2.1: aq. acetic acid / 3 h / 100 °C
3.1: H5IO6 / tetrahydrofuran / 0.08 h / 0 °C
4.1: 2.76 percent / NaBH4 / methanol / 0.08 h / -78 °C
5.1: aq. HCl; Fe; FeCl2 / ethanol / 2 h / Heating
6.1: 3.42 percent / aq. NaHCO3 / CH2Cl2 / 0.08 h / 23 °C
7.1: K2CO3 / dimethylformamide / 1 h / 23 °C
8.1: 1.91 g / PhSH / dimethylformamide / 1 h / 23 °C
9.1: 67 percent / CuI; CsOAc / dimethylsulfoxide / 24 h / 23 °C
10.1: 100 percent / imidazole / dimethylformamide / 0.17 h / 23 °C
11.1: n-BuLi / tetrahydrofuran; hexane / -78 °C
11.2: 97 percent / I2 / tetrahydrofuran; hexane / 0.33 h / -78 °C
12.1: 72 percent / PdCl2; P(o-tolyl)3; Et3N / acetonitrile / 4 h / 90 °C / Heating
13.1: 82 percent / NBS / dimethylformamide / 0.08 h / 23 °C
14.1: 100 percent / CuI; CsOAc / dimethylsulfoxide / 0.17 h / 23 °C
15.1: 77 percent / NaHCO3 / acetonitrile / 0.33 h / 70 °C
16.1: 58 percent / Zn; aq. KH2PO4 / tetrahydrofuran / 1 h / 23 °C
17.1: 83 percent / pyridine; CH2Cl2 / 0.17 h / 0 °C
18.1: 85 percent / tetrabutylammonium fluoride / tetrahydrofuran / 0.5 h / 23 °C
19.1: 88 percent / pyridine / 0.17 h / 23 °C
20.1: 81 percent / H2 / Pd/C / ethanol; ethyl acetate / 0.17 h / 23 °C
21.1: 92 percent / Cs2CO3 / acetonitrile / 1 h / 23 °C
View Scheme
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

(+)-(7bR,8aS)-methyl 4-oxo-1,2,4,5,8,8a-hexahydrocyclopropapyrrolo<3,2-e>indole-6-carboxylate
150992-82-8

(+)-(7bR,8aS)-methyl 4-oxo-1,2,4,5,8,8a-hexahydrocyclopropapyrrolo<3,2-e>indole-6-carboxylate

Conditions
ConditionsYield
With sodium methylate In methanol; acetonitrile for 1h; Ambient temperature;99%
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

duocarmycin
144667-38-9

duocarmycin

Conditions
ConditionsYield
With hydrogenchloride In ethyl acetate at 0℃; for 0.25h;96%
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

calf thymus DNA

calf thymus DNA

(+)-duocarmycin SA-adenine adduct

(+)-duocarmycin SA-adenine adduct

Conditions
ConditionsYield
With potassium phosphate buffer In N,N-dimethyl-formamide at 37℃; for 24h;81%
With sodium phosphate buffer 1.) 25 deg C, 24 h, 2.) 100 deg C, 25 min; Yield given. Multistep reaction;
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

(S)-8-Chloromethyl-4-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,4,6,7,8,8a-hexahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

(S)-8-Chloromethyl-4-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,4,6,7,8,8a-hexahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

Conditions
ConditionsYield
With hydrogenchloride In acetonitrile for 1h; Ambient temperature;
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

(S)-8-Bromomethyl-4-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,4,6,7,8,8a-hexahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

(S)-8-Bromomethyl-4-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,4,6,7,8,8a-hexahydro-pyrrolo[3,2-e]indole-2-carboxylic acid methyl ester

Conditions
ConditionsYield
With hydrogen bromide In acetonitrile for 1h; Ambient temperature;
(+)-duocarmycin SA
130288-24-3

(+)-duocarmycin SA

calf thymus DNA

calf thymus DNA

(-)-duocarmycin SA-adenine adduct

(-)-duocarmycin SA-adenine adduct

Conditions
ConditionsYield
With sodium phosphate buffer 1.) 25 deg C, 3 d, 2.) 100 deg C, 30 min; Yield given. Multistep reaction;

130288-24-3Relevant academic research and scientific papers

An Enantioselective Total Synthesis of (+)-Duocarmycin SA

Schmidt, Michael A.,Simmons, Eric M.,Wei, Carolyn S.,Park, Hyunsoo,Eastgate, Martin D.

, p. 3928 - 3940 (2018/04/14)

An efficient, concise enantioselective total synthesis of the potent antitumor antibiotic (+)-duocarmycin SA is described. The invented route is based on a disconnection strategy that was devised to facilitate rapid and efficient synthesis of key core compounds to enable preclinical structure-activity relationship investigations. The key tricycle core was constructed with a highly enantioselective indole hydrogenation to set the stereocenter and a subsequent hitherto unexplored vicarious, nucleophilic-substitution/cyclization sequence to effectively forge a final indole ring. Additionally, the development of a stable sulfonamide protecting group capable of mild chemoselective cleavage greatly enhanced sequence yield and throughput. An understanding of key reaction parameters ensured a robust, reproducible sequence easily executable on decagram scales to this highly promising class of compounds.

ENANTIOSELECTIVE SYNTHESIS OF PYRROLOINDOLE COMPOUNDS

-

, (2018/04/17)

Compounds according to formula (I) or (II), wherein R1, R2, and R3 are as defined in the specification, are versatile intermediates for the synthesis of DNA minor groove binder- alkylators having a cyclopropapyrroloindole (CPI) or seco-CPI alkylating subunit.

Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity

Tichenor, Mark S.,MacMillan, Karen S.,Trzupek, John D.,Rayl, Thomas J.,Hwang, Inkyu,Boger, Dale L.

, p. 10858 - 10869 (2008/03/13)

A systematic examination of the impact of the yatakemycin left and right subunits and their substituents is detailed along with a study of its unique three subunit arrangement (sandwiched vs extended and reversed analogues). The examination of the ca. 50 analogues prepared illustrate that within the yatakemycin three subunit structure, the subunit substituents are relatively unimportant and that it is the unique sandwiched arrangement that substantially increases the rate and optimizes the efficiency of its DNA alkylation reaction. This potentiates the cytotoxic activity of yatakemycin and its analogues overcoming limitations typically observed with more traditional compounds in the series (CC-1065, duocarmycins). Moreover, a study of the placement of the alkylation subunit within the three subunit arrangement (sandwiched vs extended and reversed analogues) indicates that it not only has a profound impact on the rate and efficiency of DNA alkylation but also controls and establishes the DNA alkylation selectivity as well, where both enantiomers of such sandwiched agents alkylate the same adenine sites exhibiting the same DNA alkylation selectivity independent of their absolute configuration.

Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: Evaluation of yatakemycin key partial structures and its unnatural enantiomer

Tichenor, Mark S.,Trzupek, John D.,Kastrinsky, David B.,Shiga, Futoshi,Hwang, Inkyu,Boger, Dale L.

, p. 15683 - 15696 (2007/10/03)

Complementary to studies that provided the first yatakemycin total synthesis resulting in its structure revision and absolute stereochemistry assignment, a second-generation asymmetric total synthesis is disclosed herein. Since the individual yatakemycin subunits are identical to those of duocarmycin SA (alkylation subunit) or CC-1065 (central and right-hand subunits), the studies also provide an improvement in our earlier total synthesis of CC-1065 and, as detailed herein, have been extended to an asymmetric total synthesis of (+)-duocarmycin SA. Further extensions of the studies provided key yatakemycin partial structures and analogues for comparative assessments. This included the definition of the DNA selectivity (adenine central to a five-base-pair AT sequence, e.g., 5′-AAAAA), efficiency, relative rate, and reversibility of ent-(-)-yatakemycin and its comparison with the natural enantiomer (identical selectivity and efficiency), structural characterization of the adenine N3 adduct confirming the nature of the DNA reaction, and comparisons of the cytotoxic activity of the natural product (L1210, IC50 = 5 pM) with those of its unnatural enantiomer (IC50 = 5 pM) and a series of key partial structures including those that probe the role of the C-terminus thiomethyl ester. The only distinguishing features between the enantiomers is that ent-(-)-yatakemycin alkylates DNA at a slower rate (krel = 0.13) and is reversible, whereas (+)-yatakemycin is not. Nonetheless, even ent-(-)-yatakemycin alkylates DNA at a faster rate and with a greater thermodynamic stability than (+)-duocarmycin SA, illustrating the unique characteristics of such "sandwiched" agents.

Total synthesis of the duocarmycins

Yamada, Ken,Kurokawa, Toshiki,Tokuyama, Hidetoshi,Fukuyama, Tohru

, p. 6630 - 6631 (2007/10/03)

The total synthesis of (+)-duocarmycin A and SA through a common indoline intermediate is described. The key reactions include selective lithiation of a 2,6-dibromoiodobenzene derivative and diastereoselective addition to a chiral nitroalkene, copper-mediated aryl amination, and addition of aryllithium to azlactones. Copyright

A novel synthesis of (+)-duocarmycin SA

Fukuda, Yasumichi,Terashima, Shiro

, p. 7207 - 7208 (2007/10/03)

The title synthesis was achieved in eight steps from (S)-5-aminoindoline (S)-4 by a method featuring sequential dehydrogenation, double bond isomerization, and oxidative cyclization of (S)-5-[(1-methoxycarbonylethyl)amino]indoline 5 as the key steps. The sequential reaction was effected by using MnO2-Pd(OAc)2 as the oxidizing agent in the presence of an acid catalyst.

Preparation of alkyl-substituted indoles in the benzene portion. Part 14. Synthesis of (±)-duocarmycin SA, natural (+)-duocarmycin SA and non-natural (-)-duocarmycin SA

Muratake,Abe,Natsume

, p. 67 - 79 (2007/10/03)

Total synthesis of duocarmycin SA (1), an extremely potent cytotoxic antibiotic, was achieved in the racemic form at first by effectively utilizing two reactions as key steps, (i) an intramolecular Heck reaction of the benzyl ether 21a, derived from a dihydropyridine 13a and a pyrrole derivative 11, to form tricyclic compounds 25a and 26a, and (ii) a modified Mitsunobu reaction on the diol derivative 40 for the construction of compound 41 having the pivotal pharmacophore of a cyclopropanoindolinone partial structure, which is critical for the high biological activities of 1. Next, optical resolution of an intermediary racemic secondary alcohol 50 was cleanly attained by derivatizing it to (R)-O-methylmandelates 52 and 53, and the resulting chiral alcohols (+)-50 and (-)-50 were respectively transformed into unnatural (-)-1 and natural (+)-1. Finally inversion of the secondary alcohol (+)-50 to the enantiomer (-)-50 was effected by using the Mitsunobu reaction. This constitutes an enantio-convergent total synthesis of natural duocarmycin SA (1) starting from a racemic compound.

Total synthesis of natural (+)-duocarmycin SA

Muratake,Matsumura,Natsume

, p. 1064 - 1066 (2007/10/02)

A total synthesis of natural (+)-duocarmycin SA (1) was achieved as shown in Chart 1, starting from L-malic acid (5) by using a Lewis acid-mediated indole formation reaction of a pyrrole precursor 14 to form the key compound 15.

Total Synthesis of an Antitumor Antibiotic, (+/-)-Duocarmycin SA

Muratake, Hideaki,Abe, Itsuko,Natsume, Mitsutaka

, p. 2573 - 2576 (2007/10/02)

A 12-step total synthesis of (+/-)-duocarmycin SA (1) was achieved from a readily available pyrrole 3 by way of 7,10/11,14 and 18, using a SnCl2-mediated reaction of a singlet oxygen adduct 6 with 5, as well as the Heck and Mitsunobu reactions on 9 and 16 as key steps.

Total synthesis and preliminary evaluation of (+)- and ent-(-)-duocarmycin SA

Boger, Dale L.,Machiya, Kozo,Hertzog, Donald L.,Kitos, Paul A.,Holmes, Daniel

, p. 9025 - 9036 (2007/10/02)

Concise total syntheses of natural (+)- and ent-(-)-duocarmycin SA (1) are detailed based on sequential regioselective nucleophilic substitution reactions of the unsymmetrical p-quinone diimine 3 in the preparation of a dihydropyrroloindole precursor to the left-hand subunit. In addition to constituting a new synthetic strategy for the preparation of natural or synthetic duocarmycins and related agents, both enantiomers of 2 (N-BOC-DSA) and its immediate synthetic precursors are made available by the approach. This provides access to synthetic analogs incorporating either enantiomer of the exceptionally stable and potent duocarmycin SA alkylation subunit. The comparative chemical properties of the agents are detailed in studies which reveal that N-BOC-DSA (t1/2 = 177 h, pH = 3; stable, pH = 7) is 4.8× more stable to chemical solvolysis than N-BOC-CPI (t1/2 = 37 h, pH = 3), the authentic alkylation subunit of CC-1065, and that the agents participate in a stereoelectronically-controlled solvolysis reaction with nucleophilic addition to the least hindered cyclopropane carbon. Consistent with this enhanced stability, (+)-N-BOC-DSA (2) proved to possess the most potent inherent cytotoxic activity of all natural and synthetic alkylation subunits examined to date including (+)-N-BOC-CPI, and its relative cytotoxic potency predictably follows a fundamental relationship between chemical stability and cytotoxic potency established in prior studies. In contrast to expectations based on past observations, the unnatural enantiomers of 1 and 2 as well as the natural enantiomers were found to constitute potent cytotoxic agents whose further examination should prove exceptionally interesting.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 130288-24-3